On Friday, Upstream Bio Inc (NASDAQ: UPB) was -5.34% drop from the session before settling in for the closing price of $8.05. A 52-week range for UPB has been $6.65 – $29.46.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 47.97%. When this article was written, the company’s average yearly earnings per share was at 57.00%. With a float of $19.15 million, this company’s outstanding shares have now reached $53.60 million.
Let’s determine the extent of company efficiency that accounts for 52 employees.
Upstream Bio Inc (UPB) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Upstream Bio Inc stocks. The insider ownership of Upstream Bio Inc is 64.29%, while institutional ownership is 40.25%. The most recent insider transaction that took place on Oct 15 ’24, was worth 14,025,000. In this transaction Director of this company bought 825,000 shares at a rate of $17.00, taking the stock ownership to the 4,554,873 shares. Before that another transaction happened on Oct 15 ’24, when Company’s Director bought 825,000 for $17.00, making the entire transaction worth $14,025,000. This insider now owns 4,554,873 shares in total.
Upstream Bio Inc (UPB) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.54 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 57.00% per share during the next fiscal year.
Upstream Bio Inc (NASDAQ: UPB) Trading Performance Indicators
You can see what Upstream Bio Inc (UPB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 44.63.
Technical Analysis of Upstream Bio Inc (UPB)
Looking closely at Upstream Bio Inc (NASDAQ: UPB), its last 5-days average volume was 0.27 million, which is a jump from its year-to-date volume of 0.25 million. As of the previous 9 days, the stock’s Stochastic %D was 13.14%. Additionally, its Average True Range was 0.89.
During the past 100 days, Upstream Bio Inc’s (UPB) raw stochastic average was set at 4.25%, which indicates a significant decrease from 27.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 93.31% in the past 14 days, which was lower than the 99.43% volatility it showed in the past 100 days.
However, in the short run, Upstream Bio Inc’s stock first resistance to watch stands at $7.89. Second resistance stands at $8.17. The third major resistance level sits at $8.37. If the price goes on to break the first support level at $7.41, it is likely to go to the next support level at $7.21. Should the price break the second support level, the third support level stands at $6.93.
Upstream Bio Inc (NASDAQ: UPB) Key Stats
There are 53,641K outstanding shares of the company, which has a market capitalization of 408.74 million. As of now, sales total 2,370 K while income totals -62,806 K. Its latest quarter income was 613 K while its last quarter net income were -21,242 K.
